Clinical Trials Logo

Diseases Genetic, Genetic clinical trials

View clinical trials related to Diseases Genetic, Genetic.

Filter by:
  • None
  • Page 1

NCT ID: NCT03054428 Completed - Dermatitis, Atopic Clinical Trials

Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis

Start date: March 21, 2017
Phase: Phase 3
Study type: Interventional

The primary objective of the study was to demonstrate the efficacy of dupilumab as a monotherapy in participants ≥12 years to <18 years of age with moderate-to-severe atopic dermatitis (AD). The secondary objective of the study was to assess the safety of dupilumab as a monotherapy in participants ≥12 years to <18 years of age with moderate-to-severe AD.